![Andrew Aromando](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Aromando
Företagsledare/Principal på
ONCOLYTICS BIOTECH INC.
Förmögenhet: 41 490 $ per 2026-07-31
Profil
Andrew P.
Aromando is Chief Business Officer at Oncolytics Biotech, Inc. since 2025.
Mr. Aromando is Chief Operating Officer at Ambrx Biopharma Cayman, Inc. since 2023.
Formerly, Mr. Aromando was SVP-Commercial Development & Operations at Tamir Biotechnology, Inc. Mr. Aromando was Vice President-North American Business Development at Innovex LP from 2000 to 2004.
Mr. Aromando was Chief Operating Officer at Ambrx Biopharma Cayman, Inc. Mr. Aromando was Chief Operating Officer at Ambrx, Inc. from 2023 to 2024.
Mr. Aromando completed undergraduate studies at The College of New Jersey and graduate studies at Rutgers State University of New Jersey.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
ONCOLYTICS BIOTECH INC. 0,05 % | 2026-06-01 | 55 100 ( 0,05 % ) | 41 490 $ | 2026-07-31 |
Aktiva positioner av Andrew Aromando
| Företag | Position | Start |
|---|---|---|
| ONCOLYTICS BIOTECH INC. | Företagsledare/Principal | 2025-06-30 |
Ambrx Biopharma, Inc.
 Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Verksamhetschef | 2023-04-28 |
Tidigare kända positioner av Andrew Aromando
| Företag | Position | Slut |
|---|---|---|
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Verksamhetschef | 2024-03-08 |
| AMBRX INC | Verksamhetschef | 2024-03-01 |
Innovex LP
 Innovex LP Miscellaneous Commercial ServicesCommercial Services Provides contract product development services | Företagsledare/Principal | 2004-01-01 |
Tamir Biotechnology, Inc.
 Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Verksamhetschef | - |
Andrew Aromandos utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
29
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Tamir Biotechnology, Inc.
Tamir Biotechnology, Inc. Medical SpecialtiesHealth Technology Engages in discovering and developing new class of therapeutic drugs | Health Technology |
Oncolytics Biotech, Inc.
 Oncolytics Biotech, Inc. BiotechnologyHealth Technology Discovers and develops pharmaceutical products for the treatment of cancers | Health Technology |
Innovex LP
Innovex LP Miscellaneous Commercial ServicesCommercial Services Provides contract product development services | Commercial Services |
The College of New Jersey
 The College of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ambrx, Inc.
 Ambrx, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
Ambrx Biopharma, Inc.
Ambrx Biopharma, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biologics company | Health Technology |
